Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juan J. Gomez-Reino
Longterm (52-Week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients With Psoriatic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Work Productivity Improvement Associated With Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results of a Phase 3, Randomized, Controlled Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
SAT0436 Durability of Apremilast Response in Patients With Psoriatic Arthritis: Long-Term (208-Week) Results From the Palace 1 Trial
A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
PMS62 Improved Fatigue and Physical Function Are Correlated With Health-Related Quality of Life in Psoriatic Arthritis Subjects Treated With Apremilast: Results From a Phase 2, Randomized, Controlled Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial
Arthritis Research & Therapy
Pss13 - Budget Impact Analysis of Apremilast in Patients With Active Psoriatic Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Cost Per Responder of Apremilast Versus Etanercept and Adalimumab in Patients With Active Psoriatic Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Risk Factors for Radiographic Progression in Psoriatic Arthritis: Subanalysis of the Randomized Controlled Trial ADEPT
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
